Profile data is unavailable for this security.
About the company
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also leveraging the clinical and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD). It is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources, which are used in cosmeceutical products, such as oat beta glucan and avenanthramides, and is being developed as potential nutraceuticals and/or pharmaceuticals. Its therapeutic development pipeline includes AIM Biologicals, AEZS-150 and AEZS-1.
- Revenue in CAD (TTM)3.23m
- Net income in CAD-24.59m
- Incorporated1990
- Employees21.00
- LocationAeterna Zentaris Inc315 Sigma DriveSUMMERVILLE 29486CanadaCAN
- Phone+1 (418) 652-8525
- Fax+1 (418) 948-9191
- Websitehttps://www.zentaris.com/
Mergers & acquisitions
| Acquired company | AEZS:TOR since announced | Transaction value |
|---|---|---|
| Ceapro Inc | 277.24% | 15.86m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ayala Pharmaceuticals Inc | 13.00k | -48.07m | 10.91m | 20.00 | -- | -- | -- | 839.55 | -7.46 | -7.46 | 0.0022 | -2.06 | -- | -- | -- | 650.00 | -- | -- | -- | -- | 0.00 | -- | -369,784.60 | -- | -- | -2.31 | -- | -- | -- | -- | -- | -- | -- | -- |
| Bon Natural Life Ltd | 29.52m | 4.60m | 10.92m | 96.00 | 0.5511 | 0.091 | 1.98 | 0.3699 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
| Moleculin Biotech Inc | 0.00 | -26.82m | 11.03m | 18.00 | -- | 0.5108 | -- | -- | -12.94 | -12.94 | 0.00 | 9.34 | 0.00 | -- | -- | 0.00 | -65.50 | -46.84 | -75.07 | -51.49 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.56 | -- | -21.54 | -- |
| CV Sciences Inc | 15.86m | -3.23m | 11.10m | 42.00 | -- | 4.70 | -- | 0.6999 | -0.0207 | -0.0207 | 0.1012 | 0.0145 | 1.59 | 1.42 | 27.25 | 377,571.40 | -32.43 | -43.42 | -83.71 | -77.75 | 45.13 | 51.81 | -20.38 | -45.68 | 0.2677 | -13.32 | 0.0472 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |
| AEterna Zentaris Inc. (USA) | 2.37m | -18.05m | 11.58m | 21.00 | -- | 0.907 | -- | 4.88 | -14.87 | -14.87 | 1.96 | 10.68 | 0.0572 | 1.52 | 6.36 | -- | -43.46 | -26.24 | -50.57 | -30.34 | 90.69 | 83.68 | -760.32 | -300.31 | 5.93 | -- | 0.0177 | -- | -20.25 | -30.06 | 27.17 | -- | 16.12 | -- |
| Galera Therapeutics Inc | 0.00 | -45.75m | 11.70m | 7.00 | -- | -- | -- | -- | -0.9971 | -0.9971 | 0.00 | -2.48 | 0.00 | -- | -- | 0.00 | -115.30 | -83.69 | -142.79 | -97.54 | -- | -- | -- | -- | -- | -6.49 | 9.23 | -- | -- | -- | 5.05 | -- | -29.84 | -- |
| Transcode Therapeutics Inc | 0.00 | -17.06m | 11.75m | 10.00 | -- | 2.25 | -- | -- | -206.36 | -206.36 | 0.00 | 0.7893 | 0.00 | -- | -- | 0.00 | -264.82 | -133.14 | -721.90 | -181.26 | -- | -- | -- | -- | -- | -148.05 | 0.00 | -- | -- | -- | -5.59 | -- | -- | -- |
| Enzolytics Inc | 0.00 | -119.19k | 11.80m | 2.00 | -- | -- | -- | -- | -0.106 | -0.106 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -369.52 | -- | -- | -- | -- | -- | -- | -- | -- | -4.30 | -- | -- | -100.00 | -- | -9.35 | -- | -- | -- |
| Sunshine Biopharma Inc | 26.74m | -4.09m | 11.87m | 44.00 | -- | 0.0251 | -- | 0.4439 | -13.35 | -13.35 | 76.96 | 24.96 | 0.9081 | 3.13 | 11.58 | 607,722.50 | -13.88 | -101.52 | -17.99 | -137.04 | 33.15 | 35.47 | -15.29 | -165.33 | 3.23 | -- | 0.00 | -- | 454.42 | -- | 83.15 | -- | 110.99 | -- |
| Pioneer Green Farms Inc | 40.05k | -537.65k | 11.94m | 6.00 | -- | -- | -- | 298.10 | -0.0228 | -0.0228 | 0.0017 | -0.0243 | 0.0664 | 1.01 | -- | 6,675.00 | -89.14 | -- | -- | -- | 26.59 | -- | -1,342.45 | -- | 0.0099 | -155.92 | 14.08 | -- | -- | -- | 35.41 | -- | -- | -- |
| Avalo Therapeutics Inc | 1.45m | -142.88m | 12.08m | 19.00 | -- | -- | -- | 8.33 | -318.69 | -318.69 | 3.02 | -97.75 | 0.0181 | -- | 3.25 | 76,315.79 | -178.64 | -99.64 | -- | -154.42 | 54.90 | 84.69 | -9,853.73 | -613.58 | -- | -0.2415 | -- | -- | -89.34 | -22.83 | 24.28 | -- | -22.48 | -- |
| Mira Pharmaceuticals Inc | 0.00 | -12.36m | 12.09m | 3.00 | -- | 3.83 | -- | -- | -0.8276 | -0.8276 | 0.00 | 0.2136 | 0.00 | -- | -- | 0.00 | -587.64 | -- | -1,721.90 | -- | -- | -- | -- | -- | -- | -2.63 | 0.00 | -- | -- | -- | -69.77 | -- | -- | -- |
| Guardion Health Sciences Inc | 12.06m | -5.12m | 12.24m | 9.00 | -- | 3.58 | -- | 1.01 | -4.00 | -4.00 | 9.49 | 2.66 | 0.9718 | 2.63 | 5.96 | 1,340,280.00 | -41.26 | -77.90 | -47.92 | -86.55 | 43.43 | 42.45 | -42.46 | -176.93 | 6.49 | -4.24 | 0.00 | -- | 10.85 | 67.03 | 101.00 | -- | -58.56 | -- |
| Marizyme Inc | 645.81k | -65.35m | 12.26m | 11.00 | -- | -- | -- | 18.98 | -1.43 | -1.43 | 0.0142 | -0.0354 | 0.0213 | 1.56 | 8.72 | 58,710.00 | -215.30 | -59.02 | -351.53 | -64.47 | 70.87 | 70.38 | -10,118.60 | -9,435.92 | 0.0458 | -0.6565 | 1.36 | -- | 176.59 | 99.98 | -71.22 | -- | -- | -- |
